| MATK |
MATK, CTK, HYL: Megakaryocyte-associated tyrosine-protein kinase |
EPHA4 |
EPHA4, HEK8, SEK, TYRO1: Ephrin type-A receptor 4 precursor |
0.848 |
Evidence |
|
| MATK |
MATK, CTK, HYL: Megakaryocyte-associated tyrosine-protein kinase |
EPHB1 |
EPHT2, EPHB1, NET: Ephrin type-B receptor 1 precursor |
0.848 |
Evidence |
|
| MATK |
MATK, CTK, HYL: Megakaryocyte-associated tyrosine-protein kinase |
EPHB3 |
EPHB3, ETK2, HEK2, TYRO6: Ephrin type-B receptor 3 precursor |
0.848 |
Evidence |
|
| MATK |
MATK, CTK, HYL: Megakaryocyte-associated tyrosine-protein kinase |
STAT2 |
STAT2: Signal transducer and activator of transcription 2 |
0.848 |
Evidence |
|
| MATK |
MATK, CTK, HYL: Megakaryocyte-associated tyrosine-protein kinase |
STAT5B |
STAT5B: Signal transducer and activator of transcription 5B |
0.848 |
Evidence |
|
| CASP2 |
CASP2, ICH1, NEDD2: Caspase-2 precursor |
EDAR |
EDAR, DL: Tumor necrosis factor receptor superfamily member EDAR precursor |
0.848 |
Evidence |
|
| STAT1 |
STAT1: Signal transducer and activator of transcription 1-alpha/beta |
PTK6 |
PTK6, BRK: Tyrosine-protein kinase 6 |
0.848 |
Evidence |
|
| STAT1 |
STAT1: Signal transducer and activator of transcription 1-alpha/beta |
ABL2 |
ABL2, ABLL, ARG: Tyrosine-protein kinase ABL2 |
0.848 |
Evidence |
|
| STAT1 |
STAT1: Signal transducer and activator of transcription 1-alpha/beta |
TXK |
TXK, PTK4: Tyrosine-protein kinase TXK |
0.848 |
Evidence |
|
| STAT1 |
STAT1: Signal transducer and activator of transcription 1-alpha/beta |
MATK |
MATK, CTK, HYL: Megakaryocyte-associated tyrosine-protein kinase |
0.848 |
Evidence |
|
| CCR2 |
CCR2, CMKBR2: C-C chemokine receptor type 2 |
CCL7 |
MCP-3: Monocyte chemotactic protein-3 |
0.848 |
Evidence |
|
| CCR2 |
CCR2, CMKBR2: C-C chemokine receptor type 2 |
CXCL12 |
Stromal cell-derived factor 1 delta |
0.848 |
Evidence |
|
| CCR2 |
CCR2, CMKBR2: C-C chemokine receptor type 2 |
CCL26 |
CCL26, SCYA26, UNQ216/PRO242: Small-inducible cytokine A26 precursor |
0.848 |
Evidence |
|
| CCR2 |
CCR2, CMKBR2: C-C chemokine receptor type 2 |
CCL13 |
CCL13, MCP4, NCC1, SCYA13: Small-inducible cytokine A13 precursor |
0.848 |
Evidence |
|
| CCR2 |
CCR2, CMKBR2: C-C chemokine receptor type 2 |
CCL15 |
CCL15, MIP5, NCC3, SCYA15: Small-inducible cytokine A15 precursor |
0.848 |
Evidence |
|
| CCR2 |
CCR2, CMKBR2: C-C chemokine receptor type 2 |
CCL14 |
CCL14, NCC2, SCYA14: Small-inducible cytokine A14 precursor |
0.848 |
Evidence |
|
| CCR2 |
CCR2, CMKBR2: C-C chemokine receptor type 2 |
CXCL9 |
CXCL9, CMK, MIG, SCYB9: Small-inducible cytokine B9 precursor |
0.848 |
Evidence |
|
| CCR2 |
CCR2, CMKBR2: C-C chemokine receptor type 2 |
CCL8 |
CCL8, MCP2, SCYA10, SCYA8: Small-inducible cytokine A8 precursor |
0.848 |
Evidence |
|
| CCR2 |
CCR2, CMKBR2: C-C chemokine receptor type 2 |
CCL11 |
CCL11, SCYA11: Eotaxin precursor |
0.848 |
Evidence |
|
| CCR2 |
CCR2, CMKBR2: C-C chemokine receptor type 2 |
XCL1 |
XCL1, LTN, SCYC1: Lymphotactin precursor |
0.848 |
Evidence |
|
| CCR2 |
CCR2, CMKBR2: C-C chemokine receptor type 2 |
CXCL5 |
CXCL5, ENA78, SCYB5: Small-inducible cytokine B5 precursor |
0.848 |
Evidence |
|
| THPO |
THPO, MGDF: Thrombopoietin precursor |
CSF2RB |
CSF2RB, IL3RB, IL5RB: Cytokine receptor common beta chain precursor |
0.848 |
Evidence |
|
| THPO |
THPO, MGDF: Thrombopoietin precursor |
IL12RB2 |
IL12RB2: Interleukin-12 receptor beta-2 chain precursor |
0.848 |
Evidence |
|
| THPO |
THPO, MGDF: Thrombopoietin precursor |
IL9R |
IL9R: Interleukin-9 receptor precursor |
0.848 |
Evidence |
|
| THPO |
THPO, MGDF: Thrombopoietin precursor |
LEPR |
LEPR, DB, OBR: Leptin receptor precursor |
0.848 |
Evidence |
|